Live from the NIH registry
Studies recruiting near Asheville right now
Top 25 of 122 recruiting studies, sorted by proximity — each links to its official registry page
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Western Carolina Retinal Associates — Asheville, North Carolina (2.1 mi)
· Sponsor: VisionCare, Inc.
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Messino Cancer Centers Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Amgen
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Parkinson Disease
Phase 2
Interventional 150 participants sought
Asheville Neurology Specialists, P.A. (Site #229) — Asheville, North Carolina (2.1 mi)
· Sponsor: Appello Pharmaceuticals, Inc.
Valved Graft PMCF Study
Aortic Valve Disease, Ascending Aorta Abnormality
N/A
Observational 260 participants sought
Mission Health & Hospitals — Asheville, North Carolina (2.1 mi)
· Sponsor: Abbott Medical Devices
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Chronic Heart Failure, CKD Stage 3
N/A
Interventional 40 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: AquaPass Medical Ltd.
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Asheville Clinical Research — Asheville, North Carolina (2.1 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Dry Eye Disease (DED)
Phase 2
Interventional 417 participants sought
Asheville Eye Associates - Regional Medical Park — Asheville, North Carolina (2.1 mi)
· Sponsor: Dompé Farmaceutici S.p.A
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Alleviant Medical, Inc.
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Pardee Cancer Center — Hendersonville, North Carolina (18.2 mi)
· Sponsor: BeOne Medicines
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Children's Oncology Group
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Asheville, North Carolina (2.1 mi)
· Sponsor: AstraZeneca
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
UNC Pardee Cancer Center — Hendersonville, North Carolina (18.2 mi)
· Sponsor: PrECOG, LLC.
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Phase 3
Interventional 400 participants sought
Allergy Partners Of West NC — Asheville, North Carolina (2.1 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: SWOG Cancer Research Network
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 540 participants sought
Digestive Health Partners - Biltmore Office /ID# 265539 — Asheville, North Carolina (2.1 mi)
· Sponsor: AbbVie
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: NRG Oncology
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 200 participants sought
Messino Cancer Center — Asheville, North Carolina (2.1 mi)
· Sponsor: Zenith Epigenetics
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 196 — Asheville, North Carolina (2.1 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Cognitive Impairment, Mild, Dementia
Phase 4
Interventional 20,000 participants sought
Asheville VA-Charles George VA Medical Center — Asheville, North Carolina (2.1 mi)
· Sponsor: Duke University
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: PedAL BCU, LLC
His-Bundle Corrective Pacing in Heart Failure
Right Bundle-Branch Block, Heart Failure
N/A
Interventional 120 participants sought
Mission Health — Asheville, North Carolina (2.1 mi)
· Sponsor: University of Rochester
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Boston Scientific Corporation
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Asheville Eye Associates, Retina Division (Site 077) — Asheville, North Carolina (2.1 mi)
· Sponsor: EyeBiotech Ltd.